These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31349001)

  • 1. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.
    Zhou SL; Zhou ZJ; Hu ZQ; Song CL; Luo YJ; Luo CB; Xin HY; Yang XR; Shi YH; Wang Z; Huang XW; Cao Y; Fan J; Zhou J
    J Hepatol; 2019 Dec; 71(6):1152-1163. PubMed ID: 31349001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection.
    Désert R; Rohart F; Canal F; Sicard M; Desille M; Renaud S; Turlin B; Bellaud P; Perret C; Clément B; Lê Cao KA; Musso O
    Hepatology; 2017 Nov; 66(5):1502-1518. PubMed ID: 28498607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.
    Li W; Wu H; Xu X; Zhang Y
    Aging (Albany NY); 2021 Apr; 13(8):11564-11594. PubMed ID: 33867349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
    Lin ZZ; Jeng YM; Hu FC; Pan HW; Tsao HW; Lai PL; Lee PH; Cheng AL; Hsu HC
    BMC Cancer; 2010 Aug; 10():461. PubMed ID: 20799978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
    Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
    Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.
    Miao R; Luo H; Zhou H; Li G; Bu D; Yang X; Zhao X; Zhang H; Liu S; Zhong Y; Zou Z; Zhao Y; Yu K; He L; Sang X; Zhong S; Huang J; Wu Y; Miksad RA; Robson SC; Jiang C; Zhao Y; Zhao H
    J Hepatol; 2014 Oct; 61(4):840-9. PubMed ID: 24859455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification.
    Torbenson M; McCabe CE; O'Brien DR; Yin J; Bainter T; Tran NH; Yasir S; Chen ZE; Dhanasekaran R; Ahn KS; Roberts LR; Wang C
    Hum Pathol; 2022 Jan; 119():15-27. PubMed ID: 34592239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H; Ooi LL; Hui KM
    PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
    Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
    J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy.
    Cai H; Zhang Y; Zhang H; Cui C; Li C; Lu S
    J Surg Oncol; 2020 May; 121(6):1007-1014. PubMed ID: 31995247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
    Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
    J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.
    Umeda S; Kanda M; Sugimoto H; Tanaka H; Hayashi M; Yamada S; Fujii T; Takami H; Niwa Y; Iwata N; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y
    BMC Cancer; 2017 Sep; 17(1):610. PubMed ID: 28863781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing.
    Liao W; Yang H; Xu H; Wang Y; Ge P; Ren J; Xu W; Lu X; Sang X; Zhong S; Zhang H; Mao Y
    Oncotarget; 2016 Jun; 7(26):40481-40490. PubMed ID: 27248174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.